Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Androgen Deprivation Withdrawal Versus Maintenance and Intermittent Chemotherapy Versus Continuous in Prostate Cancer Patients With Castrate Resistant Disease

NCT01224405 is registered in ClinicalTrials.gov with University of Turin, Italy as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01224405 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Androgen Deprivation Withdrawal Versus Maintenance and Intermittent Chemotherapy Versus Continuous in Prostate Cancer Patients With Castrate Resistant Disease
Lead sponsor
University of Turin, Italy
Phase
Phase 3
Overall status
Unknown status
Start date
April 30, 2010
Completion date
April 30, 2016
Enrollment
600 (estimated)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

advanced prostate cancer